Browsing Centre for Clinical Pharmacology by Subject "primary pci"
Now showing items 1-1 of 1
-
Bivalirudin versus heparin in primary PCI: clinical outcomes and cost analysis.
(2018)Background: The evidence for benefits of bivalirudin over heparin has recently been challenged. We aimed to analyse the safety and cost-effectiveness following reintroduction of heparin instead of bivalirudin as the standard ...